We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Appeals Court Rules in Favor of Eli Lilly in Alimta Patent Case
UK Appeals Court Rules in Favor of Eli Lilly in Alimta Patent Case
The Court of Appeal in London has upheld Eli Lilly’s vitamin regimen patent for its blockbuster cancer drug Alimta, blocking Actavis from marketing a generic version of the drug until 2021.